Once again a trial testing the erythropoiesis-stimulating agent darbepoetin alfa (Aranesp, Amgen) has produced a negative result.
FORBES: Yet Another Negative Trial For Amgen's Aranesp
应用推荐
模块上移
模块下移
不移动